- Home
- TOL vs SNN Comparison
TOL vs SNN Comparison
Compare TOL & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TOL | SNN |
|---|---|---|
| Founded | 1967 | 1856 |
| Country | United States | United Kingdom |
| Employees | N/A | 16988 |
| Industry | Homebuilding | Industrial Specialties |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.7B | 14.3B |
| IPO Year | 1994 | N/A |
Fundamental Metrics
Financial Performance| Metric | TOL | SNN |
|---|---|---|
| Price | $146.82 | $34.16 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 17 | 2 |
| Target Price | ★ $164.44 | $36.25 |
| AVG Volume (30 Days) | ★ 1.1M | 736.5K |
| Earning Date | 05-19-2026 | 03-16-2026 |
| Dividend Yield | 0.68% | ★ 2.19% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.19 | N/A |
| Revenue | ★ $7,143,258,000.00 | N/A |
| Revenue This Year | N/A | $8.58 |
| Revenue Next Year | $6.01 | $5.60 |
| P/E Ratio | $66.95 | ★ $64.97 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $93.52 | $26.02 |
| 52 Week High | $168.36 | $38.79 |
Technical Indicators
Market Signals| Indicator | TOL | SNN |
|---|---|---|
| Relative Strength Index (RSI) | 59.52 | 57.17 |
| Support Level | $128.61 | $32.03 |
| Resistance Level | $150.45 | $37.23 |
| Average True Range (ATR) | 3.81 | 0.57 |
| MACD | 1.58 | 0.28 |
| Stochastic Oscillator | 85.13 | 83.48 |
Price Performance
Historical ComparisonAbout TOL Toll Brothers Inc.
Toll Brothers Inc is the luxury homebuilder in the USA, operating in over 60 markets across 24 states. The Fort Washington, Pennsylvania-headquartered homebuilder caters to affluent first-time, move-up, active-adult, and second-homebuyers. Toll Brothers has shifted in recent years to a greater mix of speculative, or "quick move-in" homes. The homebuilder has also expanded its price points, with a greater emphasis on "affordable luxury. Traditional homebuilding accounts for the majority of Toll Brothers' earnings, but the firm also offers ancillary mortgage, title, insurance, and other services.
About SNN Smith & Nephew SNATS Inc.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.